RS10774021 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:Chronic kidney disease]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Deoxycarnitine levels | T | OR: 0.35 | 1E-241 | PubMed |
| 1-methylimidazoleacetate levels | T | OR: 0.35 | 2E-232 | PubMed |
| Deoxycarnitine levels | C | OR: 0.35 | 1E-138 | PubMed |
| Deoxycarnitine levels | T | OR: 0.35 | 3E-135 | PubMed |
| 1-methyl-4-imidazoleacetate levels | T | OR: 0.36 | 5E-125 | PubMed |
| 1-methylimidazoleacetate levels | C | OR: 0.35 | 1E-109 | PubMed |
| 3-aminoisobutyrate levels | T | OR: 0.23 | 2E-106 | PubMed |
| Imidazole lactate levels | T | OR: 0.21 | 2E-90 | PubMed |
| Estimated glomerular filtration rate (creatinine) | T | β: 0.034 | 6E-55 | PubMed |
| Creatinine levels in bottom 99% of individuals by creatinine levels | — | OR: 0.37 | 2E-47 | PubMed |
| Plasma deoxycarnitine levels in chronic kidney disease | T | OR: 0.1 | 1E-43 | PubMed |
| Imidazole lactate levels | T | OR: 0.19 | 1E-34 | PubMed |
| Glutamine degradant levels | T | OR: 0.15 | 1E-27 | PubMed |
| Estimated glomerular filtration rate based on creatinine and cystatin C in bottom 99% of individuals by creatinine levels | — | OR: 2.57 | 1E-23 | PubMed |
| Bicarbonate (mean, inv-norm transformed) | C | β: 0.026 | 1E-22 | PubMed |
| Estimated glomerular filtration rate (creatinine, cystatin c) | T | β: 0.021 | 2E-22 | PubMed |
| X-25419 levels | T | OR: 0.19 | 5E-22 | PubMed |
| 1-ribosyl-imidazoleacetate (X-11334) levels | C | OR: 0.15 | 9E-21 | PubMed |
| Body mass index (BMI, minimum, inv-normal transformed) | C | β: 0.025 | 1E-18 | PubMed |
| creatinine (minimum, inv-norm transformed) | C | β: 0.021 | 2E-17 | PubMed |